التفاصيل البيبلوغرافية
| العنوان: |
Cell Transfer Therapy for Cancer: Past, Present, and Future. |
| المؤلفون: |
Xiaoling Qian1, Xian Wang1, Hongchuan Jin1 jinhc@srrsh.com |
| المصدر: |
Journal of Immunology Research. 2014, p1-9. 9p. |
| مصطلحات موضوعية: |
*STEM cell transplantation, *CANCER treatment, *IMMUNOTHERAPY, *LYMPHOCYTES, *DENDRITIC cells, *CANCER chemotherapy |
| مستخلص: |
Cell transfer therapy for cancer has made a rapid progress recently and the immunotherapy has been recognized as the fourth anticancer modality after operation, chemotherapy, and radiotherapy. Lymphocytes used for cell transfer therapy include dendritic cells, natural killer (NK) cells, and T lymphocytes such as tumor-infiltrating lymphocytes (TILs) and cytotoxic T lymphocytes (CTLs). In vitro activated or engineered immune cells can traffic to cancer tissues to elicit persistent antitumor immune response which is very important especially after immunosuppressive treatments such as chemotherapy. In this review, we overviewed recent advances in the exploration of dendritic cells, NK cells, and T cells for the treatment of human cancer cells. [ABSTRACT FROM AUTHOR] |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder